Sandoz Group AG (OTCMKTS:SDZNY – Get Free Report)’s share price reached a new 52-week high during trading on Monday . The stock traded as high as $45.21 and last traded at $45.07, with a volume of 40387 shares changing hands. The stock had previously closed at $44.17.
Wall Street Analyst Weigh In
Separately, Royal Bank of Canada lowered Sandoz Group from a “moderate buy” rating to a “hold” rating in a research note on Monday, September 16th.
Get Our Latest Analysis on SDZNY
Sandoz Group Trading Up 2.0 %
Sandoz Group Company Profile
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Featured Articles
- Five stocks we like better than Sandoz Group
- What is a Special Dividend?
- Inflation Risk Rising, Key Trades Investors Are Making Now
- Canadian Penny Stocks: Can They Make You Rich?
- 3 Oil Stocks to Watch Before Earnings Come Out
- What is Insider Trading? What You Can Learn from Insider Trading
- Is American Express Stock’s Sell-the-News Reaction a Buying Opp?
Receive News & Ratings for Sandoz Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandoz Group and related companies with MarketBeat.com's FREE daily email newsletter.
